Literature DB >> 9836381

Anti-CD4 monoclonal antibodies in rheumatoid arthritis.

E H Choy1, G H Kingsley, G S Panayi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9836381     DOI： 10.1007/bf00832011

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  56 in total

1.  Elevated levels of circulating tumor necrosis factor-alpha, interferon-gamma, and interleukin-2 in systemic reactions induced by anti-CD4 therapy in patients with rheumatoid arthritis.

Authors:  G Horneff; A Krause; F Emmrich; J R Kalden; G R Burmester
Journal:  Cytokine       Date:  1991-05       Impact factor: 3.861

2.  Monoclonal antibody treatment in rheumatoid arthritis: the clinical and immunological effects of a CD7 monoclonal antibody.

Authors:  B W Kirkham; C Pitzalis; G H Kingsley; I C Chikanza; S Sabharwal; C Barbatis; R Grahame; T Gibson; P L Amlot; G S Panayi
Journal:  Br J Rheumatol       Date:  1991-12

Review 3.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis.

Authors:  P K Gregersen; J Silver; R J Winchester
Journal:  Arthritis Rheum       Date:  1987-11

4.  Functional interaction between human T-cell protein CD4 and the major histocompatibility complex HLA-DR antigen.

Authors:  D Gay; P Maddon; R Sekaly; M A Talle; M Godfrey; E Long; G Goldstein; L Chess; R Axel; J Kappler
Journal:  Nature       Date:  1987 Aug 13-19       Impact factor: 49.962

5.  Separation of functional subsets of human T cells by a monoclonal antibody.

Authors:  E L Reinherz; P C Kung; G Goldstein; S F Schlossman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  Increase of poly(ADP-ribose) polymerase mRNA levels during TPA-induced differentiation of human lymphocytes.

Authors:  M Menegazzi; H Suzuki; A Carcereri de Prati; M Tommasi; M Miwa; G Gandini; F Gerosa
Journal:  FEBS Lett       Date:  1992-02-03       Impact factor: 4.124

7.  A double-blind, placebo-controlled study of anti-CD5 immunoconjugate in patients with rheumatoid arthritis. The Xoma RA Investigator Group.

Authors:  N J Olsen; R H Brooks; J J Cush; P E Lipsky; E W St Clair; E L Matteson; K N Gold; G W Cannon; C G Jackson; W J McCune; D A Fox; B Nelson; T Lorenz; V Strand
Journal:  Arthritis Rheum       Date:  1996-07

8.  Percentage of anti-CD4 monoclonal antibody-coated lymphocytes in the rheumatoid joint is associated with clinical improvement. Implications for the development of immunotherapeutic dosing regimens.

Authors:  E H Choy; C Pitzalis; A Cauli; J A Bijl; A Schantz; J Woody; G H Kingsley; G S Panayi
Journal:  Arthritis Rheum       Date:  1996-01

9.  Treatment of rats with monoclonal anti-CD4 induces long-term resistance to streptococcal cell wall-induced arthritis.

Authors:  M F Van den Broek; L G Van de Langerijt; M C Van Bruggen; M E Billingham; W B Van den Berg
Journal:  Eur J Immunol       Date:  1992-01       Impact factor: 5.532

10.  Cytokines in chronic inflammatory arthritis. I. Failure to detect T cell lymphokines (interleukin 2 and interleukin 3) and presence of macrophage colony-stimulating factor (CSF-1) and a novel mast cell growth factor in rheumatoid synovitis.

Authors:  G S Firestein; W D Xu; K Townsend; D Broide; J Alvaro-Gracia; A Glasebrook; N J Zvaifler
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307
View more
  5 in total

1.  Building towards a consensus for the use of tumour necrosis factor blocking agents.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  Developments in therapy with monoclonal antibodies and related proteins.

Authors:  H Michael Shepard; Gail Lewis Phillips; Christopher D Thanos; Marc Feldmann
Journal:  Clin Med (Lond)       Date:  2017-06       Impact factor: 2.659

3.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

Review 4.  CD20-Mimotope Peptide Active Immunotherapy in Systemic Lupus Erythematosus and a Reappraisal of Vaccination Strategies in Rheumatic Diseases.

Authors:  Elvira Favoino; Marcella Prete; Andrea Marzullo; Enrico Millo; Yehuda Shoenfeld; Federico Perosa
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 5.  Rheumatiod Arthritis: An Updated Overview of Latest Therapy and Drug Delivery.

Authors:  Disha Kesharwani; Rishi Paliwal; Trilochan Satapathy; Swarnali Das Paul
Journal:  J Pharmacopuncture       Date:  2019-12-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.